
Peptide Madness! fdli.org/2026/11/when-a-lice…

Former FDA Associate Commissioner. President @DrugWonks. Visiting Professor. Champion for smart policy, radical transparency & patient access. #FDA #DrugPolicy

Peptide Madness! fdli.org/2026/11/when-a-lice…

Qualifying Single Source Drug Policy and Incentives for Post-Approval Innovation publichealth.realclearjourna…

GLOBE Goes to Court. American Innovation Is on Trial. realclearhealth.com/articles…

The COINS Act: Penny Wise, Patient Foolish realclearhealth.com/articles…

CMS could soon finalize its latest Medicare drug price negotiation rules. The agency should drop a provision that could discourage innovations that give cancer patients valuable time back. Read my latest in @InsideSourcesDC: dcjournal.com/medicares-drug…

GLOBE: A World of Bad Ideas for American Patients realclearhealth.com/articles…

FDA Should Practice the Science It Preaches realclearhealth.com/blog/202…

Medicare’s Drug Rule Could Penalize Better Treatments dcjournal.com/medicares-drug…

Access to the right medical device is critical to quality care. Thank you @RepGregMurphy & @RepSchneider for calling to reevaluate urology and ostomy products in competitive bidding, giving policymakers, providers, and patient advocates time to address care concerns.

FDA's new Karim sky hook. realclearhealth.com/articles…

Can I get an "Amen." realclearhealth.com/articles…

Righting 340B. Don't give up the ship! thewellnews.com/opinions/rig…

The COVID-19 trust recession: why the next pandemic will be won – or l… sciencedirect.com/science/ar…

Some good news out of Atlanta ... realclearhealth.com/articles…

The Uncomfortable Truth About Hospital Price Transparency youtube.com/shorts/nMwzO_Ksx… via @YouTube

The Semaglutide Shortage Is Over and So Is the Excuse realclearhealth.com/articles…